<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11594">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01904006</url>
  </required_header>
  <id_info>
    <org_study_id>IVISEV-003AGR</org_study_id>
    <nct_id>NCT01904006</nct_id>
  </id_info>
  <brief_title>Human Embryo Group Culture vs. Standard Single Drop Culture</brief_title>
  <acronym>AGRUPADO</acronym>
  <official_title>Evaluation and Development of a New in Vitro Embryo Group Culture at Low Oxygen Tension at the Embryology Laboratory</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Sevilla</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Sevilla</source>
  <oversight_info>
    <authority>Spain: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous studies in human and different mammals have proved that the embryo group culture
      (in the same culture medium drop) using a reduced volume is associated with a better embryo
      development. This is due to the effect of different autocrine and paracrine factors secreted
      by the embryos. Besides, previous studies with embryos from human and other mammals have
      shown that a high oxygen concentration may have a negative effect on embryo quality due to
      the generation of reactive oxygen species, which cause oxidative stress. The embryo culture
      at low oxygen tension is correlated to better success rates in IVF/ICSI treatments.

      The purpose of this study is to evaluate the combined effect of the embryo group culture and
      the low oxygen tension on the embryo development and the results of the IVF/ICSI treatments.
      The specific goal is to compare the embryo group culture in a reduced volume of medium at a
      low oxygen tension (5%) with the standard individual culture at an atmospheric oxygen
      tension (20%). The first culture condition will be applied in a K-MINC incubator (COOK
      Medical®), whereas the second condition will be applied using a Heracell incubator
      (Heraeus®).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>June 2013 - August 2014</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>June 2013 - Ausgust 2014</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancy rate</measure>
    <time_frame>June 2013 - Ausgust 2014</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo quality</measure>
    <time_frame>June 2013 - Ausgust 2014</time_frame>
    <safety_issue>No</safety_issue>
    <description>According to ASEBIR criteria (grades A-D)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">182</enrollment>
  <condition>Embryo Group Culture</condition>
  <arm_group>
    <arm_group_label>Group culture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The embryos will be cultured in groups of 5 embryos per medium drop.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard culture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The embryos will be culture individually (each embryo in one medium drop).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group culture</intervention_name>
    <description>The embryos will be cultured in groups of 5 embryos per medium drop. The culture will be performed inside a MINC incubator, at a low oxygen tension (5%).</description>
    <arm_group_label>Group culture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard culture</intervention_name>
    <description>The embryos will be cultured individually (each embryo in one medium drop). The culture will be performed inside an Heraeus incubator, at an atmospheric oxygen tension (20%).</description>
    <arm_group_label>Standard culture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt;38 years (with own oocytes) / &lt;45 years (with oocyte donation).

          -  First treatment with own oocytes / any treatment with oocyte donation.

          -  ≥10 oocytes with a diameter of ≥10 mm.

        Exclusion Criteria:

          -  Diseases that affect endometrial receptivity: endometriosis, hydrosalpinx, ovarian
             hyperstimulation syndrome, obesity, endocrinopathies, thrombophilia, congenital or
             acquired uterine anomalies.

          -  Patients under a treatment with genetic preimplantation diagnosis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Blasco, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolas Prados, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Myriam Ruiz, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rocio Quiroga, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Fernandez, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IVI Sevilla</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Victor Blasco, MSc</last_name>
    <phone>+34954286274</phone>
    <email>victor.blasco@ivi.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolas Prados, PhD</last_name>
    <phone>+34954286274</phone>
    <email>nicolas.prados@ivi.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IVI Sevilla</name>
      <address>
        <city>Seville</city>
        <zip>41006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Blasco, MSc</last_name>
      <phone>+34954286274</phone>
      <email>victor.blasco@ivi.es</email>
    </contact>
    <contact_backup>
      <last_name>Nicolas Prados, PhD</last_name>
      <phone>+34954286274</phone>
      <email>nicolas.prados@ivi.es</email>
    </contact_backup>
    <investigator>
      <last_name>Victor Blasco, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocio Quiroga, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Prados, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Myriam Ruiz, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Fernandez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 12, 2014</lastchanged_date>
  <firstreceived_date>July 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Embryo, group,low oxygen tension, assisted reproduction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
